Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Senvest Management, LLC ACLS Axcelis Technologies Inc 13G/A 0% 2y
Periscope Capital Inc. SBXC SilverBox Corp III 13G 9% 2y
Saba Capital Management, L.P. ANGX Angel Studios, Inc. 13G/A 0% 2y
JENNISON ASSOCIATES LLC TRN Trinity Industries Inc 13G/A 4.5% 2y
Frederick W. Smith FDX Fedex Corp 13G/A 8.3% 2y
Polar Asset Management Partners Inc. OCEA Ocean Biomedical, Inc. 13G/A 7.7% 2y
GIC Private Ltd DASH DoorDash, Inc. 13G/A 5.46% 2y
MORGAN STANLEY FPF First Trust Intermediate Duration Preferred & Income Fund 13G/A 9.8% 2y
Blue Foundry Bank Employee Stock Ownership Plan Trust BLFY Blue Foundry Bancorp 13G/A 9.3% 2y
Brian Choi OPBK OP Bancorp 13G/A 8.62% 2y
Highland Management Partners VIII Limited TDUP ThredUp Inc. 13G/A 9% 2y
MORGAN STANLEY MAPS Wm Technology, Inc. 13G 6.4% 2y
LSV ASSET MANAGEMENT IRWD Ironwood Pharmaceuticals Inc 13G/A 4.35% 2y
MANAGED ACCOUNT ADVISORS, LLC OWL Blue Owl Capital Inc. 13G 6.6% 2y
MORGAN STANLEY IOT Samsara Inc. 13G/A 7.8% 2y
MORGAN STANLEY TKO TKO Group Holdings, Inc. 13G 5.1% 2y
Saba Capital Management, L.P. WQGA World Quantum Growth Acquisition Corp. 13G/A 0% 2y
Periscope Capital Inc. EONR EON Resources Inc. 13G 7.8% 2y
Periscope Capital Inc. VSAC Vision Sensing Acquisition Corp. Class A Common Stock 13G/A 0% 2y
PNC FINANCIAL SERVICES GROUP, INC. LLY ELI LILLY & Co 13G/A 5.43% 2y
Polar Asset Management Partners Inc. CLOE Clover Leaf Capital Corp. Class A Common Stock 13G/A 0% 2y
Opaleye Management Inc. JNCE Jounce Therapeutics, Inc. Common Stock 13G 0% 2y
JUPITER ASSET MANAGEMENT LTD KD Kyndryl Holdings, Inc. 13G 4.69% 2y
Steven Ira Sarowitz PCTY Paylocity Holding Corp 13G/A 17.1% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD GF New Germany Fund Inc 13G/A 7.2% 2y
Samjo Management, LLC INSE Inspired Entertainment, Inc. 13G 8.6% 2y
MORGAN STANLEY DORM Dorman Products, Inc. 13G/A 7.3% 2y
PRINCIPAL FINANCIAL GROUP INC WMS Advanced Drainage Systems, Inc. 13G/A 9% 2y
Polar Asset Management Partners Inc. ARTE Artemis Strategic Investment Corporation Class A Common Stock 13G/A 0% 2y
MANAGED ACCOUNT ADVISORS, LLC DENN DENNY'S CORP 13G 5.6% 2y
Periscope Capital Inc. CNDA Concord Acquisition Corp II 13G 9.1% 2y
Artal Participations S.a r.l KRSA Korsana Biosciences, Inc. 13G/A 5.7% 2y
CSS LLC/IL AMZE Amaze Holdings, Inc. 13G/A 6.32% 2y
MORGAN STANLEY PGZ Principal Real Estate Income Fund 13G/A 6.4% 2y
Jackson Square Partners, LLC GO Grocery Outlet Holding Corp. 13G/A 4.46% 2y
CSS LLC/IL SPE Special Opportunities Fund, Inc. 13G/A 5.68% 2y
Saba Capital Management, L.P. TBSA TB SA Acquisition Corp Class A Ordinary Share 13G/A 0% 2y
MORGAN STANLEY NFJ Virtus Dividend, Interest & Premium Strategy Fund 13G/A 6.7% 2y
Polar Asset Management Partners Inc. CDAQF Compass Digital Acquisition Corp. 13G 8.6% 2y
HarbourVest Partners L.P. OMGA Omega Therapeutics, Inc. Common Stock 13G/A 6.4% 2y
Sound Financial Bancorp, Inc. Employee Stock Ownership Plan SFBC Sound Financial Bancorp, Inc. 13G/A 6.7% 2y
PNC FINANCIAL SERVICES GROUP, INC. ACLO TCW ETF Trust 13G 5.63% 2y
MORGAN STANLEY TFX Teleflex Inc 13G/A 5.5% 2y
Shanglue Xiao YJ Yunji Inc. 13G/A 48.7% 2y
MORGAN STANLEY ORGO Organogenesis Holdings Inc. 13G 8.7% 2y
Cantillon Capital Management LLC BC Brunswick Corp 13G/A 3.91% 2y
Periscope Capital Inc. CCG Cheche Group Inc. 13G/A 0% 2y
Periscope Capital Inc. FATP Fat Projects Acquisition Corp Class A Ordinary Share 13G/A 0% 2y
MORGAN STANLEY CWCO Consolidated Water Co. Ltd. 13G/A 5.6% 2y
MORGAN STANLEY RIGL Rigel Pharmaceuticals Inc 13G 8.3% 2y